Utah Medical Products, Inc. (UTMD) Reports Q2 Earnings of $0.54, Sales Up 65% Y/Y
Tweet
Share
E-mailGet Alerts UTMD Hot Sheet
Price: $72.10 -0.04%
Financial Fact:
Research and development: 135K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 135K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Utah Medical Products, Inc. (NASDAQ: UTMD) reported Q2 EPS of $0.54, versus $0.40 reported last year. Revenue for the quarter came in at $10.38 million, versus $6.28 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
